In recent years, cancer medicine has been transformed by precise molecular data used to identify, diagnose, and treat this disease. The precision of molecular data in medicine helps researchers to not only look at the disease from a clinical perspective but also from the genetic perspective of each patient and to find effective treatments tailored for an individual patient. The OmicsLogic Bioinformatics for Precision Oncology program was designed to help participants learn about the various -Omics Data types used to characterize cancer as well as discuss methods of analysis, annotation, and interpretation of NGS data associated with cancer onset, development, and outcomes. The program offers bioinformatics skills for life science researchers to contribute to the study of precision medicine in cancer research.
Olga Udartseva is a Postdoctoral Researcher focused on Cellular and Molecular Biology at Roswell Park Comprehensive Cancer Center. She is a clinical researcher and her research focus is in tumor immunology. She is also an expert in, CRISPR, Multicolor Flow Cytometry, Molecular Biology, Cell Culture, and Immunofluorescence.
Olga recently completed the Bioinformatics for Precision Oncology program where she took online courses on cancer biology that can be studied by analyzing multi-omics data types. As a result of completing multiple courses and developing a research project which she had a chance to present to program mentors, she received a certificate of excellence for the program:
The certification confirms her active participation, completion of over 5 online courses on the TBioInfo training portal and completion of bioinformatics pipelines using the T-BioInfo Analytical Server. Olga is currently working on an independent bioinformatics project of her own studying the Role of IL-1 Pathway in Prostate Cancer Progression.
Precision Oncology is the way forward in cancer research and drug development as it highlights the need to personalize treatments for patients. By incorporating insights from molecular data, treatments are more targeted and have a better chance of being effective. This batch of Bioinformatics for Precision Oncology program has now ended, as the participants are now taking their time to work on their individual projects.
For others interested in learning more about Bioinformatics for Precision Oncology, we have an upcoming program – Bioinformatics for Precision Medicine that will cover some of the topics that we spoke about in the previous program as well as how it can also be used to treat viral diseases like COVID1-9 and also in relation to vaccine development.
If you are interested, you can sign up here: https://edu.tbioinfo.com/bioinformatics-for-precision-medicine-2020
We also offer a Research Internship option to students and researchers interested in working in this domain. For more details about the internship, please visit: https://edu.tbioinfo.com/bioinformatics-internship-2020
If you have any comments or further questions, please contact: firstname.lastname@example.org